Population-based studies including systematic echocardiographic examinations are
required to assess the prevalence of valvular heart disease. In industrialized countries, the …

Valvular heart disease remains common in industrialized countries, because the decrease
in prevalence of rheumatic heart diseases has been accompanied by an increase in that of …

Valvular heart diseases (VHDs), as a group, are among the most predictable causes of heart
failure (HF)[1]. They are also potentially lethal, particularly among patients who have been …

Background Valvular heart diseases are not usually regarded as a major public-health
problem. Our aim was to assess their prevalence and effect on overall survival in the general …

Background The epidemiology of valvular heart disease (VHD) has changed markedly over
the last 50 years worldwide, and the prevalence and features of VHD in China are unknown …

Valvular heart disease (VHD) is a major contributor to loss of physical function, quality of life
and longevity. The epidemiology of VHD varies substantially around the world, with a …

Valve replacement has been one of the most important advances in the management of
patients with valvular heart disease. The 10 and 15 year survival rate after isolated aortic …

Valvular heart disease is a rapidly growing cause of global cardiovascular morbidity and
mortality with diverse and evolving geographic distribution. The prevalence of rheumatic …

Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …

Background—Unlike the Western world, valvular disease ranks among the major
cardiovascular afflictions in Africa. Acute rheumatic fever and chronic rheumatic valvular …